TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
JRS Pharma Oy
Closing information (x1000 DKK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
81,094
|
84,689
|
82,998 |
Financial expenses |
15
![]() |
15
|
22 |
Earnings before taxes |
16,408
|
15,768
|
13,021 |
Total assets |
49,171
|
43,631
|
51,855 |
Current assets |
22,809
|
16,044
|
24,390 |
Current liabilities |
10,877
|
11,634
|
10,900 |
Equity capital |
37,811
|
31,319
|
40,174 |
- share capital |
1,249
|
1,254
|
1,251 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
76.9%
|
71.8%
|
77.5% |
Turnover per employee | |||
Profit as a percentage of turnover |
20.2%
|
18.6%
|
15.7% |
Return on assets (ROA) |
33.4%
|
36.2%
|
25.2% |
Current ratio |
209.7%
|
137.9%
|
223.8% |
Return on equity (ROE) |
43.4%
|
50.3%
|
32.4% |
Change turnover |
-3,279
|
1,500
|
8,420 |
Change turnover % |
-4%
|
2%
|
11% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.